http://rdf.ncbi.nlm.nih.gov/pubchem/reference/18783057

Outgoing Links

Predicate Object
contentType Clinical Trial, Phase III|Journal Article|Multicenter Study|Randomized Controlled Trial
endingPage 2368
issn 0959-8049
issueIdentifier 15
pageRange 2361-2368
publicationName European journal of cancer (Oxford, England : 1990)
startingPage 2361
bibliographicCitation Monk BJ, Herzog TJ, Kaye SB, Krasner CN, Vermorken JB, Muggia FM, Pujade-Lauraine E, Park YC, Parekh TV, Poveda AM. Trabectedin plus pegylated liposomal doxorubicin (PLD) versus PLD in recurrent ovarian cancer: overall survival analysis. Eur J Cancer. 2012 Oct;48(15):2361–8. doi: 10.1016/j.ejca.2012.04.001. PMID: 22541893.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_55ce49d67fd0a8691c51d62829cc0b99
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_273bcbc423ff39c0a8f813e4faf003b4
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1fd12035643c0aaae8cf686010a40473
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5f509622debdb158b39f0cead2ac336b
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2b035ccfd6fd6fd70757a6f8935d4ed7
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cd6ef2dfcfd5cb769c7160e3205ed266
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d9d1ac2466baba5afbac7971dbaec7e7
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_41c46cfd8f439cf945a6900228195062
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1b12b582350db37b0f8d34c15f911b44
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3ef5de130da61563405f30599e6992a8
date 201210
identifier https://pubmed.ncbi.nlm.nih.gov/22541893
https://doi.org/10.1016/j.ejca.2012.04.001
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/1697
https://portal.issn.org/resource/ISSN/0959-8049
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title Trabectedin plus pegylated liposomal doxorubicin (PLD) versus PLD in recurrent ovarian cancer: Overall survival analysis
discusses http://id.nlm.nih.gov/mesh/M0017182
http://id.nlm.nih.gov/mesh/M0001348
http://id.nlm.nih.gov/mesh/M0006784
http://id.nlm.nih.gov/mesh/M0444141
http://id.nlm.nih.gov/mesh/M0006500
http://id.nlm.nih.gov/mesh/M0417713
http://id.nlm.nih.gov/mesh/M0453081
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D011092Q000627
http://id.nlm.nih.gov/mesh/D000903Q000627
http://id.nlm.nih.gov/mesh/D004317Q000031
http://id.nlm.nih.gov/mesh/D000971Q000627
http://id.nlm.nih.gov/mesh/D010051Q000188
http://id.nlm.nih.gov/mesh/D009375Q000188
hasSubjectTerm http://id.nlm.nih.gov/mesh/D016019
http://id.nlm.nih.gov/mesh/D005260
http://id.nlm.nih.gov/mesh/D011092Q000008
http://id.nlm.nih.gov/mesh/D004317Q000008
http://id.nlm.nih.gov/mesh/D009364
http://id.nlm.nih.gov/mesh/D000077216
http://id.nlm.nih.gov/mesh/D018572
http://id.nlm.nih.gov/mesh/D004317Q000627
http://id.nlm.nih.gov/mesh/D008875
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D000903Q000008
http://id.nlm.nih.gov/mesh/D000368
http://id.nlm.nih.gov/mesh/D044005Q000008
http://id.nlm.nih.gov/mesh/D004149Q000008
http://id.nlm.nih.gov/mesh/D009375Q000473
http://id.nlm.nih.gov/mesh/D010051Q000473
http://id.nlm.nih.gov/mesh/D000077606
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID108150
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8752
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54688400
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23939

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID248774860

Total number of triples: 62.